期刊文献+

硝酸银和不同粒径纳米银在大鼠体内的急性毒性作用及生物分布研究

Acute toxicity and bio-distribution of silver nitrate and nano-silver with different particle diameters in rats
原文传递
导出
摘要 目的探讨硝酸银和2种粒径纳米银对大鼠的急性毒性作用及蓄积靶器官。方法选取36只成年SD大鼠,按照随机数字表法分为小粒径纳米银组、大粒径纳米银组、硝酸银组和对照组,每组9只。上述4组大鼠分别经尾静脉一次性注射10mg/mL纳米银溶液(纳米银颗粒直径为20nm,生理盐水配制),银注射剂量为30mg/kg;10mg/mL纳米银溶液(纳米银颗粒直径为100nm,生理盐水配制),银注射剂量为30mg/kg;1.67mg/mL硝酸银溶液(葡萄糖溶液配制),银注射剂量为3mg/kg;30mg/mL聚乙烯吡咯烷酮溶液(生理盐水配制),注射剂量为90mg/kg。(1)毒性实验。注射后14d内每日行大体观察,记录注射前分别与注射后1、7、14d的体质量差值。于注射后1、7、14d每组各取3只大鼠,采用全自动生化分析仪检测血清中ALT、AST、总蛋白、白蛋白含量;之后立即处死大鼠,取心脏、肝脏、脾脏、肺脏、肾脏和大脑组织,计算各个脏器系数。选取脏器系数变化明显的脏器标本,每组各时相点3个样本,行HE染色观察组织病理学变化。(2)生物分布实验。选取小粒径纳米银组、大粒径纳米银组、硝酸银组大鼠的心脏、肝脏、脾脏、肺脏、肾脏标本,每组各时相点3个样本,采用电感耦合等离子体质谱仪检测各脏器银含量。对数据行析因设计方差分析、LSD检验、Dun-nett’s T3检验。结果(1)对照组和硝酸银组大鼠注射后大体情况无异常;2个纳米银组大鼠注射后ld}十;现状态不佳、眼部有黑色分泌物等现象,注射后3d起恢复。(2)与对照组比较,硝酸银组、大粒径纳米银组大鼠注射后14d与注射前的体质量差值明显减少(P值均小于0.01);小粒径纳米银组大鼠该指标则与之接近(P〉0.05)。与对照组比较,另3组大鼠注射后1、7d与注射前的体质量差值无明显变化(P值均大于0.05)。(3)与对照组比较,注射后1d硝酸银组大鼠血清中总蛋白含量下降、肝脏系数明显上升(P值均小于0.05)。注射后1d,大粒径纳米银组大鼠血清中ALT含量为(61.0±8.7)U/L,明显高于对照组的(40.0±4.6)U/L,P〈0.01。与对照组的(126.0±3.5)U/L、4.05±0.23比较,注射后1d小粒径纳米银组、大粒径纳米银组大鼠血清中AST含量明显上升[(249.7±107.2)、(237.0±38.3)U/L],肝脏系数(3.50±0.38、3.31±0.07)明显下降,P值均小于0.05。与对照组的(69.2±d.8)U/L、4.32±0.39比较,注射后7d小粒径纳米银组、大粒径纳米银组大鼠血清中AST含量[(181.0±51.5)、(167.7±16.5)U/L]亦明显上升,肝脏系数(3.55±0.18、3.62±0.21)亦明显下降,P〈0.05或P〈0.01。与对照组比较,注射后14d另3组大鼠血清中4项肝脏生化指标、各个脏器系数均无明显变化(P值均大于0.05)。(4)注射后1d,硝酸银组大鼠肝脏有轻微变性;注射后7d,小粒径纳米银组大鼠肝脏中央静脉周同肝细胞轻微变性,大粒径纳米银组大鼠肝脏肝细胞重度嗜酸性变。其余时相点各组大鼠的肝脏无明显病理改变。(5)注射后1d,小粒径纳米银组大鼠肺脏、肾脏与大粒径纳米银组大鼠脾脏、肾脏及注射后7d2个纳米银组大鼠心脏、肾脏的银含量明显少于硝酸银组(P值均小于0.05),注射后1dd小粒径纳米银组大鼠肝脏、脾脏的银含量明显多于硝酸银组(P值均小于0.05)。与硝酸银组比较,大粒径纳米银组大鼠注射后1d肺脏及注射后7d肝脏的银含量明显增多(P值均小于0.05),注射后14d各脏器银含量无明显变化(P值均大于0.05)。大粒径纳米银组大鼠注射后1d心脏、肺脏、肾脏及注射后7d心脏的银含量明显多于小粒径纳米银组(P值均小于0.05),注射后14d2组大鼠各脏器银含量相近(P值均大于0.05)。结论硝酸银和2种粒径的纳米银对大鼠的肝脏有短暂的急性毒性作用,肝脏对这种毒性作用有一定的自愈能力。纳米银主要蓄积于肝脏,大粒径纳米银在脏器中的分布较小粒径纳米银更广。 Objective To explore the acute toxic effect and the cumulative target organ of silver ni- trate and nano-silver with two different particle diameters in rats. Methods Thirty-six adult SD rats were divided into small particle size nano-silver group (SNS) , large particle size nano-silver group (LNS) , silver nitrate group (SN), and control group (C) according to the random number table, with 9 rats in each group. The rats of the four groups were respectively injected with 10 mg/mL nano-silver solution (particle diameter of 20 nm, prepared by saline) in silver dose of 30 mg/kg by tail vein for once, 10 mg/mL nano-silver solution (particle diameter of 100 nm, prepared by saline) in silver dose of 30 mg/kg, 1.67 mg/mL sil- ver nitrate solution (prepared by glueose solution) in silver dose of 3 mg/kg, and 30 mg/mL polyvinylpyrrolidone solution (prepared by saline) in dose of 90 mg/kg. (1) Toxicity test. The general observation was performed within 14 days after injection, and the deviation between value of body mass before injection and each of that on post injection day (PID) 1, 7, and 14 were respectively recorded. On PID 1, 7, and 14, 3 rats of each group were harvested for determination of serum content of alanine aminotransferase (ALT) , aspartate aminotransferase (AST) , total protein, and albumin by fully automatic bioehemical analyzer. Then the rats were sacrificed immediately, and heart tissue, liver tissue, spleen tissue, lung tissue, kidney tis- sue, and brain tissue were eolleeted to calculate the organ coeffieient. Organ samples with obvious ehanges in organ coefficient were eolleeted for histopathologieal observation by HE staining, with 3 samples in each group at each time point. (2) Bio-distribution. The specimens of heart, liver, spleen, lung, and kidney of rats from groups SNS, LNS, and SN were eolleeted for detection of silver content by inductively coupled plasma mass speetrometry, with 3 samples in each group at each time point. Data were proeessed with analysis of variance of faetorial design, LSD test, and Dunnett's T3 test. Results ( 1 ) The general condition of rats in groups C and SN after injection were normal. The state of rats of groups SNS and LNS was poor with black secretion in the eye and other phenomena on PID 1 , whieh recovered from PID 3 on. (2) The de- viations between values of body mass before injection and that on PID 14 in rats of groups LNS and SN were significantly deereased as compared with deviation of group C ( with P values below 0.01 ) , but deviation of group SNS was not significantly changed ( P 〉 0.05 ). The deviations between values of body mass before injection and eaeh of that on PID 1 and 7 in rats in the other three groups were similar to those in group C ( with P values above 0.05). (3) Compared with those in group C, the serum content of total protein of rats in group SN on PID 1 was signifieantly decreased, and liver coefficient was significantly increased ( with P values below0.05). On PID 1, the serum eontent of ALT of rats in group LNS was (61.0 ±8.7) U/L, which was signifieantly higher than that in group C [ (40.0 ±4.6) U/L, P 〈0.01 ]. Compared with those in group C [(126.0±3.5) U/L and 4.05 ±0.231, the serum content of AST of rats in groups SNS and LNS on PID 1 [ (249.7 ± 107.2) and (237.0 ± 38.3 ) U/L] was significantly increased, and liver eoeffi- eients (3.50 ±0.38 and 3.31 ±0.07 ) were significantly decreased, with P values below 0.05. Compared with those in group C [(69.2±4.8) U/L and 4.32±0.39], the serum content of AST of rats in groups SNS and LNS on PID 7 [(181.0±51.5) and (167.7±16.5) U/L] was also significantly increased, and liver coefficients (3.55 ±0.18 and 3.62 ±0.21 ) were also significantly decreased, P 〈 0.05 or P 〈 0.01. On PID 14, the four liver biochemieal indexes in serum and all organ eoefficients of rats in the other three groups were similar to those in group C ( with P values above 0.05). (4) The liver of rats in group SN had slight degeneration on PID 1 , the liver eells around the central vein of liver of rats in group SNS had slight degeneration on PID 7, and the liver cells got severely eosinophilic degeneration in liver of rats in group LNS on PID 7. There was no signifieant pathological ehange in the liver of rats in eaeh group at the rest time points. (5) The silver content of lung and kidney in rats of group SNS on PID 1 , that of spleen and kidney in rats of group LNS on PID 1 , and that of heart and kidney in rats of groups LNS and SNS on PID 7 was signifieantly less than that of group SN ( with P values below 0.05 ). The silver content of liver and spleen in rats of group SNS on PID 14 was significantly more than that of group SN (with P values below 0.05 ). Com- pared with that of group SN, the silver content of lung on PID 1 and liver on PID 7 in rats of group LNS was significantly increased ( with P values below 0.05). On PID 14, there was no significant change in the silver content of all organs of rats between group SN and group LNS ( with P values above 0.05 ). The silver eontent of heart, lung, and kidney on PID 1 and heart on PID 7 in rats of group LNS was significantly more than that of group SNS ( with P values below 0.05 ). On PID 14, the silver content of each organ of rats in group SNS was close to that in group LNS ( with P values above 0.05 ). Conclusions Silver nitrate and nanosilver with two different particle diameters have a short acute toxic effect on the liver of rats, and the liver has certain ability of self-healing. Nano-silver is mainly accumulated in the liver. The distribution of nano-silver with large particle diameter in organs is more widely than that of nano-silver with small particle diameter.
出处 《中华烧伤杂志》 CAS CSCD 北大核心 2016年第10期606-612,共7页 Chinese Journal of Burns
基金 国家重点基础研究发展计划(2011CB933404) 国家自然科学基金(81573186、81502783、81473003、81302461) 江苏省普通高校研究生科研创新计划(SJLX15-0073)
关键词 金属纳米粒子 硝酸银 毒性作用 生物分布 Metal nanoparticles Silver Silver nitrate Toxic actions Bio-distribution
  • 相关文献

参考文献15

  • 1Mishra A, Sardar M. Cellulase assisted synthesis of nano-silver and gold: application as immobilization matrix for biocatalysis [J]. Int J BiolMacromol, 2015, 77: 105-113.
  • 2吕庆兵,于冶,肖贵喜,包亚明,贾立平,胡亮,陆静.浸浴结合银离子敷料治疗大面积烧伤患者残余创面的疗效[J].中华烧伤杂志,2013,29(2):203-204. 被引量:18
  • 3张劲峰,郝建波,张劲鹏,罗波,刘鹏.生物敷料的研究进展[J].中国修复重建外科杂志,2015,29(2):254-259. 被引量:24
  • 4有传刚,韩春茂,王新刚,孙华凤,胡信雷.纳米银的抗菌和毒性机制及临床研究进展[J].中华烧伤杂志,2011,27(3):243-246. 被引量:15
  • 5Xue Y, Zhang S, Huang Y, et al. Acute toxic effects and gen- der-related biokinetics of silver nanopartieles following an intrave- nous injection in mice[ J]. J Appl Toxieol, 2012, 32 ( 11 ) : 890- 899.
  • 6张姗姗,薛玉英,唐萌,张婷,刘晓闰,张鹏,张智勇.纳米银在小鼠体内的组织分布[J].东南大学学报(自然科学版),2012,42(2):388-392. 被引量:9
  • 7van der Zande M, Vandebriel RJ, Van Doren E, et al. Distribu- tion, elimination, and toxicity of silver nanoparticles and silver i- ons in rats after 28-day oral exposure [J]. ACS Nano, 2012, 6 (8) :7427-7442.
  • 8硅谷高科技公司化学物质毒性数据库[DB/OL].旧金山:硅谷高科技公司,2016[2016-02-03].http://www.dgfl-ture.com/toxic/q102-q445.html.
  • 9张帮勇,巩凡,黄艳梅,张婷,薛玉英,唐萌.纳米银对肝细胞体外增殖作用的实验研究[J].环境与健康杂志,2014,31(10):897-900. 被引量:3
  • 10Tiwari DK, Jin T, Behari J. Dose-dependent in-vivo toxicity as- sessment of silver nanoparticle in Wistar rats [ J]. Toxicol Mech Methods, 2011, 21 (1): 13-24.

二级参考文献151

共引文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部